Non Hodgkin Lymphoma
Showing 26 - 50 of 127
Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)
Active, not recruiting
- Non Hodgkin Lymphoma
- Magrolimab
- +3 more
-
Birmingham, Alabama
- +19 more
Dec 8, 2022
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)
Recruiting
- Non Hodgkin Lymphoma
- +3 more
-
Washington, District of Columbia
- +5 more
Nov 29, 2022
Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin Lymphoma
- UF-KURE19 CAR-T cells
- +2 more
-
Cleveland, Ohio
- +1 more
Nov 21, 2022
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)
Recruiting
- Nasopharyngeal Carcinoma
- +8 more
-
Springdale, ArkansasHighlands Oncology
Nov 11, 2022
Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)
Not yet recruiting
- Non Hodgkin Lymphoma
- Neuropsychological testing
-
San Francisco, CaliforniaStanford Cancer Center
Nov 9, 2022
Immunogenicity of COVID-19 Vaccinations in Autologous HSCT
Not yet recruiting
- COVID-19
- +2 more
-
Cologne, NRW, GermanyUniversity Hospital of Cologne
Oct 27, 2022
Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)
Active, not recruiting
- Non Hodgkin Lymphoma
- R-CHOP + acalabrutinib
-
Southampton, Hampshire, United Kingdom
- +6 more
Oct 26, 2022
Auto/Allo Tandem Transplant for Relapsed B-NHL
Completed
- Non Hodgkin Lymphoma
- auto transplant followed by allo transplant
- (no location specified)
Oct 24, 2022
Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)
Recruiting
- Breast Cancer
- Non Hodgkin Lymphoma
-
Middlesbrough, Teesside, United KingdomSouth Tees Hospitals NHS FT
Oct 20, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T
Recruiting
- Non Hodgkin Lymphoma
- +2 more
- Fully human anti CD19 CAR-T Cell Dose
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Oct 4, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
-
Birmingham, Alabama
- +49 more
Sep 21, 2022
Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)
Recruiting
- Mantle Cell Lymphoma
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 13, 2022
Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +7 more
-
Brussels, Brussel, BelgiumUz Brussel
Sep 2, 2022
Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)
Active, not recruiting
- Non Hodgkin Lymphoma
- UCD19 CAR T Cells
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 1, 2022
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,
Recruiting
- Lymphoma, Non-Hodgkin
- +6 more
- CB-010
- +2 more
-
Scottsdale, Arizona
- +7 more
Aug 19, 2022